Antimicrobial

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical…

1 day ago
Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot InfectionsRecce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Recce Pharmaceuticals Receives Approval for Additional Phase II Trial of RECCE® 327 Topical Gel for Diabetic Foot Infections

Human Research Ethics Committee (HREC) approval received to allow up to 20 additional patients access to RECCE® 327 Topical Gel…

1 day ago
Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar DefenderBest Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender

Best Berberine Supplement: Top Berberine Supplements For Weight Loss & Blood Sugar From Sugar Defender

Best Berberine Supplement for Weight loss and Blood sugar. It is used for centuries in traditional medicine, berberine is now…

1 week ago
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of DirectorsPhathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors

FLORHAM PARK, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing…

1 week ago
Spectrum Vascular Welcomes New Executive LeadershipSpectrum Vascular Welcomes New Executive Leadership

Spectrum Vascular Welcomes New Executive Leadership

WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Spectrum Vascular (“Spectrum” or the “Company”), a provider of vascular access and medication management products designed to…

1 week ago
Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™

Microban International Wins Silver Edison Award for Sustainable Antimicrobial Technology Ascera™

HUNTERSVILLE, N.C., April 10, 2025 /PRNewswire/ -- Microban International, the leader in antimicrobial solutions, has been awarded the silver Edison…

2 weeks ago
Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant RecipientsTheriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and…

2 weeks ago
Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to ShareholdersRecce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

A$5.0 million commitment received from Australian-based private investorA$10.8 million Entitlement Offer at the same offer price as the placementFunds to…

2 weeks ago
The ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of DirectorsThe ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of Directors

The ‘Father of Modern Food and Drug Law,’ Peter Hutt, Joins EVŌQ Nano Board of Directors

Hutt Brings Decades of Regulatory Insight to Help Advance Nanoparticle Technology Platform SALT LAKE CITY, April 9, 2025 /PRNewswire/ --…

2 weeks ago
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment AutomationSeegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation

Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire…

2 weeks ago